Aisling Capital’s Asensus Surgical, Inc. ASXC Stock Holding History

Aisling Capital’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.48M	Hold	183,796	–	–	3.27%	4
2019 Q2	$3.23M	Hold	183,796	–	–	5.35%	3
2019 Q1	$5.69M	Hold	183,796	–	–	8.55%	3
2018 Q4	$5.4M	Hold	183,796	–	–	1.53%	4
2018 Q3	$13.9M	Sell	183,796 -307,693	-63%	-$20.8M	2.99%	5
2018 Q2	$27.9M	Sell	491,489 -269,230	-35%	-$9.81M	3.66%	4
2018 Q1	$16.8M	Hold	760,719	–	–	3%	4
2017 Q4	$19.1M	Sell	760,719 -34,344	-4%	-$1.06M	3.77%	4
2017 Q3	$14.8M	Hold	795,063	–	–	2.43%	5
2017 Q2	$7.34M	Buy	795,063 +153,846	+24%	+$1.46M	1.26%	10
2017 Q1	$10.1M	Hold	641,217	–	–	1.84%	9
2016 Q4	$10.8M	Hold	641,217	–	–	2.52%	9
2016 Q3	$14.1M	Hold	641,217	–	–	2.9%	12
2016 Q2	$10.2M	Hold	641,217	–	–	2.4%	15
2016 Q1	$35.4M	Hold	641,217	–	–	7.09%	4
2015 Q4	$20.7M	Hold	641,217	–	–	3.57%	11
2015 Q3	$18.8M	Hold	641,217	–	–	3.31%	12
2015 Q2	$25M	Hold	641,217	–	–	3.72%	11
2015 Q1	$24.4M	Hold	641,217	–	–	3.2%	11
2014 Q4	$24.3M	Hold	641,217	–	–	3.68%	11
2014 Q3	$36.3M	Hold	641,217	–	–	7.05%	8
2014 Q2	$42M	Buy	+641,217	New	+$37M	12.14%	2

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aisling Capital's ASXC Position: Q3 2019 in Review

Aisling Capital held its Asensus Surgical, Inc. (ASXC) position steady in Q3 2019 at 183,796 shares worth $1.48M. The position accounts for 3.27% of the portfolio, ranked #4.

Aisling Capital first reported a position in ASXC in Q2 2014 and has held it in 22 quarters since. The position peaked at $42M in Q2 2014. 130 funds tracked by Wall St. Rank hold ASXC as of Q3 2019.

Aisling Capital held 183,796 shares of Asensus Surgical, Inc. worth $1.48M as of Q3 2019.
Aisling Capital left its Asensus Surgical, Inc. share count unchanged in Q3 2019.
Asensus Surgical, Inc. made up 3.27% of Aisling Capital's portfolio in Q3 2019, its #4 holding.
Aisling Capital first reported a position in Asensus Surgical, Inc. in Q2 2014 and has held it in 22 quarters since.
Aisling Capital's Asensus Surgical, Inc. position peaked at $42M in Q2 2014.
130 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2019.

Based on Aisling Capital's 13F filing for Q3 2019, filed 13 Nov 2019.